JavadKVMSaifMKalathilB,et al.Sensorineural hearing loss as an atypical presentation of typhoid fever: A case report. Trop Dr2024; 0(0).
2.
BarkumeCDateKSahaSK, et al.Phase I of the Surveillance for Enteric Fever in Asia Project (SEAP): an overview and lessons learned. J Infect Dis2018; 218: S188–S194.
3.
ThompsonCNKarkeyADongolS, et al.Treatment response in enteric fever in an era of increasing antimicrobial resistance: an individual patient data analysis of 2092 participants enrolled into 4 randomized, controlled trials in Nepal. Clin Infect Dis2017; 64: 1522–1531.
4.
IqbalJDehrajIFCareyME, et al.A race against time: reduced azithromycin susceptibility in Salmonella enterica Serovar Typhi in Pakistan. mSphere2020; 5: e00215–20.
5.
ParryCMHoVAPhuong leT, et al.Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Antimicrob Agents Chemother2007; 51: 819–825.
6.
ZmoraNShresthaSNeubergerA, et al.Open label comparative trial of mono versus dual antibiotic therapy for Typhoid Fever in adults. PLoS Negl Trop Dis2018; 12: e0006380.
7.
GiriAKarkeyADongolS, et al.Azithromycin and cefixime combination versus azithromycin alone for the out-patient treatment of clinically suspected or confirmed uncomplicated typhoid fever in South Asia: a randomised controlled trial protocol. Wellcome Open Res2021; 6: 207.
